SINGAPORE — French pharmaceutical giant Sanofi on Wednesday opened a 800 million Singapore dollar ($595 million) modular vaccine and biopharmaceutical facility in Singapore — the only such facility ...
Sanofi SA added a new plant in Singapore to make vaccines and other medicines, as the French pharmaceutical group seeks to bolster preparedness for emergencies, including potential pandemics. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results